This morning, Monday May 24th, Enveric Biosciences (NASDAQ: ENVB) announced that it has entered an agreement to acquire privately held biotechnology company MagicMed Industries. MagicMed has a state-of-the-art facility at the University of Calgary, which it uses to perform extensive R&D on naturally occurring psychedelic molecules. Their focus is the discovery and early development of … Continue reading MagicMed: Finding the Derivative with Dr. Joseph Tucker